These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 18690987)
1. Immune monitoring to predict the development of infections after immunosuppression for solid organ transplantation and autoimmune diseases. Carbone J; Lanio N; Gallego A; Sarmiento E Curr Drug Saf; 2008 May; 3(2):91-9. PubMed ID: 18690987 [TBL] [Abstract][Full Text] [Related]
2. Immunological risk factors for infection after immunosuppressive and biologic therapies. Carbone J; del Pozo N; Gallego A; Sarmiento E Expert Rev Anti Infect Ther; 2011 Apr; 9(4):405-13. PubMed ID: 21504398 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases. Looney RJ; Diamond B; Holers VM; Levesque MC; Moreland L; Nahm MH; St Clair EW; Clin Immunol; 2007 Jun; 123(3):235-43. PubMed ID: 17329169 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients. Page AV; Liles WC Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545 [TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086 [TBL] [Abstract][Full Text] [Related]
6. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence. Dendle C; Mulley WR; Holdsworth S Transplant Rev (Orlando); 2019 Apr; 33(2):87-98. PubMed ID: 30551846 [TBL] [Abstract][Full Text] [Related]
7. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies]. Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771 [TBL] [Abstract][Full Text] [Related]
8. No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients. Ingvar Å; Ekström Smedby K; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J Acta Derm Venereol; 2012 Nov; 92(6):609-14. PubMed ID: 22293782 [TBL] [Abstract][Full Text] [Related]
9. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial. Drabe CH; Sørensen SS; Rasmussen A; Perch M; Gustafsson F; Rezahosseini O; Lundgren JD; Ostrowski SR; Nielsen SD BMC Infect Dis; 2019 Jul; 19(1):573. PubMed ID: 31269923 [TBL] [Abstract][Full Text] [Related]
10. [Infections in organ transplantations]. Holzinger C; Buxbaum P; Laczkovics A; Domanig E; Wolner E Zentralbl Chir; 1990; 115(17):1091-9. PubMed ID: 2173865 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of specific humoral and cellular immune responses against the major capsid L1 protein of cutaneous wart-associated alpha-Papillomaviruses in solid organ transplant recipients. Gaiser MR; Textor S; Senger T; Schädlich L; Waterboer T; Kaufmann AM; Süsal C; Pawlita M; Enk AH; Gissmann L; Lonsdorf AS J Dermatol Sci; 2015 Jan; 77(1):37-45. PubMed ID: 25439730 [TBL] [Abstract][Full Text] [Related]
12. Infectious complications in pediatric solid organ transplantation. Keough WL; Michaels MG Pediatr Clin North Am; 2003 Dec; 50(6):1451-69, x. PubMed ID: 14710787 [TBL] [Abstract][Full Text] [Related]
13. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation. Stratta RJ; Pietrangeli C; Baillie GM Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989 [TBL] [Abstract][Full Text] [Related]
14. Polymorphonuclear leukocyte functions as predictive markers for infections after organ transplantation. Egger G; Burda A; Hengster P; Kunc M; Margreiter R Transpl Int; 2000; 13(2):114-21. PubMed ID: 10836647 [TBL] [Abstract][Full Text] [Related]
15. "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. De Paolis P; Favarò A; Piola A; Martini F; Cristiana G; Agrati C; Iappelli M; Di Giulio S Transplant Proc; 2011 May; 43(4):1013-6. PubMed ID: 21620039 [TBL] [Abstract][Full Text] [Related]
16. Infection in organ transplantation: risk factors and evolving patterns of infection. Fishman JA; Issa NC Infect Dis Clin North Am; 2010 Jun; 24(2):273-83. PubMed ID: 20466270 [TBL] [Abstract][Full Text] [Related]
17. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy. Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E; Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364 [TBL] [Abstract][Full Text] [Related]
18. Secondary Hypogammaglobulinemia: An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation. Kaplan B; Bonagura VR Immunol Allergy Clin North Am; 2019 Feb; 39(1):31-47. PubMed ID: 30466771 [TBL] [Abstract][Full Text] [Related]
19. Viral infections in pediatric solid organ transplantation recipients and the impact of molecular diagnostic testing. Madan RP; Herold BC Curr Opin Organ Transplant; 2010 Jun; 15(3):293-300. PubMed ID: 20445449 [TBL] [Abstract][Full Text] [Related]
20. Mortality predictors of bloodstream infections in solid-organ transplant recipients. Wan Q; Ye Q; Zhou J Exp Clin Transplant; 2013 Jun; 11(3):211-4. PubMed ID: 23190439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]